Company: HURA
Filing Date: 2025-05-23
Form Type: 424B3
Source: 0001193125-25-125499
Chunk: 726

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-05-23
Form: 424B3
Chunk 726
---
 brokerage account, or if you hold registered shares, for TuHURA stockholders, please call (813) 875-6600, or write to 10500 University Center Dr., Suite 110, Tampa, FL 33612, and for Kineta
stockholders, please call (206) 378-0400 or write to 7683 SE 27th Street, Suite 481, Mercer Island, WA 98040.

Requests for additional copies of this joint proxy statement/prospectus should be directed to, as applicable: TuHURA Biosciences, Inc., 10500
University Center Dr., Suite 110, Tampa, FL 33612, Telephone (813) 875-6600, or Kineta, Inc., 7683 SE 27th Street, Suite 481, Mercer Island, WA 98040, Telephone (206)
378-0400.

493

ADDITIONAL INFORMATION

TUHURA Annual Report

Copies of
TuHURA’s Annual Report on Form 10-K (including TuHURA’s audited financial statements) filed with the SEC may be obtained without charge by writing to TuHURA Biosciences, Inc., 10500 University Center
Dr., Suite 110, Tampa, FL 33612, Telephone (813) 875-6600. Exhibits to the Form 10-K will be mailed upon similar request and payment of specified fees to cover the costs
of copying and mailing such materials.

TuHURA’s audited financial statements for the fiscal year ended December 31, 2024 and
certain other related financial and business information are contained in TuHURA’s Annual Report on Form 10-K, which is being made available to TuHURA’s stockholders along with this proxy statement,
but which is not deemed a part of the proxy soliciting material.

Kineta Annual Report

Copies of Kineta’s Annual Report on Form 10-K (including Kineta’s audited financial
statements) filed with the SEC may be obtained without charge by writing to Kineta, Inc., 7683 SE 27th Street, Suite 481, Mercer Island, WA 98040, Telephone (206) 378-0400. Exhibits to the Form 10-K will be mailed upon similar request and payment of specified fees to cover the costs of copying and mailing such materials.

Kineta’s audited financial statements for the fiscal year ended December 31, 2024 and certain other related